Skip to main content
Clinical Trials/NCT04911283
NCT04911283CompletedNot Applicable

Mehmet Akif İnan Education and Research Hospital

Veysel Delen1 site in 1 country118 target enrollmentStarted: May 1, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
118
Locations
1
Primary Endpoint
Serology for brucellosis

Study Overview

Brief Summary

Objective: This study aims to examine Brucella serology and history of brucellosis in patients with lumbar Modic changes (MCs) type 1, considering results from cross-sectional and case-control comparisons.

Design: In comparative cross-sectional design, MCs type 1 patients (study group) and MCs type 2 patients (comparator group) were examined in terms of Brucella serology by using agglutination with Coombs test. In addition, in comparative case-control design, both of the MCs groups and age/sex-matched healthy controls were investigated for their medical history regarding brucellosis.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients with lumbar Modic changes type 1
  • Patients with lumbar Modic changes type 2
  • Participant who given informed consent for the study

Exclusion Criteria

  • Patients aged<18 years
  • History of serious lumbar trauma
  • Lumbar spinal surgery
  • Scoliosis
  • Cooperation disorder

Outcomes

Primary Outcomes

Serology for brucellosis

Time Frame: 30 minutes

History of brucellosis

Time Frame: 7 minutes

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Veysel Delen
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Veysel Delen

Department of Physical Medicine and Rehabilitation

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Study Sites (1)

Loading locations...

Similar Trials